4th Department of Pediatrics, "G.Papageorgiou" General Hospital School of Medicine, Department of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Department of Pediatrics, "G. Gennimatas" General Hospital of Thessaloniki, Thessaloniki, Greece.
Pediatrics. 2024 Dec 1;154(6). doi: 10.1542/peds.2024-066758.
The prevention of urinary tract infection recurrence (UTI) in children has been a challenge yet to be solved. Current practice in children with recurrent UTI (RUTI) suggests that antibiotic prophylaxis may prevent further episodes of UTI and future complications.
To conduct a systematic review and meta-analysis of randomized controlled trials comparing prophylaxis options for the prevention of UTI and kidney scarring in children with a history of RUTI.
We conducted a systematic literature search through major electronic databases (PubMed/Medline, Scopus and Cochrane Library) up to November 26th, 2023. Mean difference and SD were used for continuous outcomes and odds ratio for dichotomous outcomes.
Our meta-analysis included 3335 participants from 23 studies.
The primary outcome was the effect of the different prophylaxis options on the incidence of symptomatic UTI in children with RUTI during prophylactic treatment.
Cranberry products and nitrofurantoin lead to lower odds of symptomatic UTI episodes during prophylaxis compared with the control group and control, trimethoprim-sulfamethoxazole, or trimethoprim groups accordingly. Nitrofurantoin may be the best option for UTI incidence reduction compared with all available documented interventions.
No prophylaxis option has been shown to reduce kidney scarring.
Nitrofurantoin and cranberry products may decrease the incidence of symptomatic UTI episodes in pediatric patients with a history of RUTI. Future randomized control trials studying nonantibiotic prophylaxis options focusing on children with UTI recurrence and the risk for kidney scarring are needed to draw further conclusions.
预防儿童尿路感染复发(UTI)一直是一个尚未解决的挑战。目前,对于复发性尿路感染(RUTI)患儿的治疗建议是,抗生素预防治疗可能预防 UTI 进一步发作和未来的并发症。
系统评价和荟萃分析比较了预防 RUTI 患儿 UTI 和肾脏瘢痕形成的各种预防方案。
我们通过主要电子数据库(PubMed/Medline、Scopus 和 Cochrane Library)进行了系统的文献检索,检索截止日期为 2023 年 11 月 26 日。连续结局采用均数差和标准差表示,二分类结局采用比值比表示。
我们的荟萃分析纳入了 23 项研究的 3335 名参与者。
主要结局是不同预防方案对 RUTI 患儿预防治疗期间症状性 UTI 发生率的影响。
与对照组和对照组(三氨嘧啶-磺胺甲噁唑、三氨嘧啶)相比,蔓越莓产品和呋喃妥因在预防治疗期间发生症状性 UTI 发作的可能性较低。与所有可用的有记录的干预措施相比,呋喃妥因可能是降低 UTI 发生率的最佳选择。
没有预防方案被证明可以减少肾脏瘢痕形成。
呋喃妥因和蔓越莓产品可能会降低 RUTI 患儿发生症状性 UTI 发作的频率。需要进一步研究非抗生素预防方案,以观察其在预防 RUTI 复发和肾脏瘢痕形成风险方面的效果,为后续结论提供依据。